Read More...The Dental Oncology Complication that Wouldn’t Go Away">
Site Overlay

The Dental Oncology Complication that Wouldn’t Go Away


Authors: Conor Barry,CS Weadick,Harriet Byrne,Richeal Ni Riordain,Seamus O'Reilly
Publication: Journal of The Irish Head and Neck Society - 2023
Issue: 1 Volume: 1
Published: June, 2023 View PDF

Bone-modifying agents are used throughout cancer care to improve quality of life after cancer treatment. As survival rates of cancer patients have increased significantly, complications arising after cancer-treatment are becoming more prevalent. Medication-related osteonecrosis of the jaw (MRONJ) is a direct consequent of bone-modifying agents (BMAs). Dental disease remains the most common non-communicable disease and has remained stagnant in 45% of the world’s population over the past thirty years. Dental disease is a strong predictor of future MRONJ. The condition was first described two decades ago, and is a relevant clinical consideration given the guidance-based incorporation of BMAs in both metastatic and adjuvant settings. In this instance, increasing cancer-related survival has been paralleled by increased BMA exposure and consequently higher risk of MRONJ. We report a patient with a history of metastatic breast cancer whose quality of survival has been dominated by advanced stage MRONJ. We discuss the management of her care and the need for primary dental prevention to be integrated into oncology care for patients on BMAs.

Tell us what went wrong - include any error codes & a screenshot if possible
Upload a screenshot if you have it
Accepted file types: jpg, gif, png, pdf, heic, doc, docx, Max. file size: 50 MB.
This field is for validation purposes and should be left unchanged.

This will close in 0 seconds